Howmet Aerospace Completes Early Redemption of 5.87% Notes Due 2022
Get Alerts HWM Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.2%
Revenue Growth %: +19.3%
Join SI Premium – FREE
PITTSBURGH--(BUSINESS WIRE)-- Howmet Aerospace Inc. (NYSE: HWM) announced today that it has completed the early redemption of all of its outstanding 5.87% Notes due 2022 (the “2022 Notes”) in the aggregate principal amount of $476.2 million. The 2022 Notes were redeemed with cash on hand at an aggregate redemption price of approximately $503.3 million, including accrued interest. Following the redemption of the 2022 Notes, the Company’s next debt maturity is in October 2024.
About Howmet Aerospace
Howmet Aerospace Inc., headquartered in Pittsburgh, Pennsylvania, is a leading global provider of advanced engineered solutions for the aerospace and transportation industries. The Company’s primary businesses focus on jet engine components, aerospace fastening systems, and titanium structural parts necessary for mission-critical performance and efficiency in aerospace and defense applications, as well as forged wheels for commercial transportation. With nearly 1,150 granted and pending patents, the Company’s differentiated technologies enable lighter, more fuel-efficient aircraft to operate with a lower carbon footprint. For more information, visit www.howmet.com. For more information, visit www.howmet.com. Follow: LinkedIn, Twitter, Instagram, Facebook, and YouTube.
Dissemination of Company Information
Howmet Aerospace intends to make future announcements regarding Company developments and financial performance through its website at www.howmet.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210503005723/en/
Investor Contact
Paul T. Luther
(412) 553-1950
[email protected]
Media Contact
Paul Erwin
(412) 553-2666
[email protected]
Source: Howmet Aerospace Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States
- Ripple’s XRP Meets AI Trading: AIXAlpha Launches Free AI Strategy Contracts with Daily Settlement
- VEVOR Launches "Beat the Heat at Home" Summer Comfort Lineup for Outdoor Living
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share